
ASCO/X
Nov 16, 2024, 09:57
Targeting expression in metastatic breast cancer – ASCO
ASCO posted the following on X:
“Though ADCs have emerged as a cutting-edge approach to chemotherapy, determining when and how to assess targets in patients with metastatic breast cancer remains an evolving challenge. Yara Abdou and Paola Zagami discuss in a new editorial for ASCO Daily News.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 20, 2025, 11:30
Mar 20, 2025, 11:18
Mar 20, 2025, 11:01
Mar 20, 2025, 10:35
Mar 20, 2025, 10:23